Dasatinib-Induced Colitis with Rectal Sparing in a Patient with Chronic Myeloid Leukemia (Chronic Phase) on Dasatinib as an Upfront Therapy: Case Report

Dasatinib is a BCR-ABL tyrosine kinase inhibitor which was approved in 2006 for the treatment of adults diagnosed with Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML) in chronic phase (CP) and accelerated (myeloid or lymphoid blast) phase and CML with resistance or intolerance...

Full description

Saved in:
Bibliographic Details
Main Authors: Zakaria Maat, Kamran Mushtaq, Mohamed A. Yassin
Format: article
Language:EN
Published: Karger Publishers 2021
Subjects:
Online Access:https://doaj.org/article/7fb3f050297a4c249b0e5b71cb52312b
Tags: Add Tag
No Tags, Be the first to tag this record!